Justices Told Fed. Circ. Wrongly Kills Patents PTAB Upholds
Baxter Corp. has urged the U.S. Supreme Court to review a Federal Circuit decision invalidating its telepharmacy patent after it was upheld in an inter partes review, saying the case illustrates...To view the full article, register now.
Already a subscriber? Click here to view full article